# Extranodal natural killer/T-cell lymphoma with tonsil involvement: a case report

**Authors:** Yang Xiao, Xing Zhang, Yingqin Gao, Ken Lin, Wenyue Chi, Kaijian Zhou, Jing Ma, Tiesong Zhang

PMC · DOI: 10.1186/s12903-024-04452-x · BMC Oral Health · 2024-07-30

## TL;DR

A rare case of a type of lymphoma involving the tonsils in a child was successfully treated with chemotherapy.

## Contribution

This paper reports a rare pediatric case of ENKTL with tonsil involvement and its successful treatment with the SMILE regimen.

## Key findings

- A 13-year-old girl was diagnosed with stage II ENKTL involving the tonsils.
- The patient achieved complete response after six cycles of SMILE chemotherapy and remained recurrence-free.
- Immunohistochemistry and genetic testing confirmed the diagnosis of ENKTL.

## Abstract

Extranodal natural killer/T-cell lymphoma (ENKTL) with tonsil involvement is not common, especially in children.

A 13-year-old girl presented with an unexplained sore throat for more than 2 months, together with intermittent fever and suppurative tonsilitis. Nasopharyngoscopy revealed a pharyngeal mass. Enhanced computed tomography (CT) scan showed tonsillar hypertrophy and punctate calcification. Chronic pyogenic granulomatous inflammation with pseudoepithelial squamous epithelial hyperplasia was observed in left tonsil, and pyogenic granulomatous inflammation and a small number of T-lymphoid cells were detected in the right tonsil. The immunohistochemical results showed CD2+, CD3+, CD4+, CD5+, CD8+, granzyme B+, and TIA-1+. The Ki-67 proliferation index was 20%. The case showed T cell receptor gene rearrangement. Finally, the case was diagnosed as ENKTL of stage II with tonsil involvement. The patient received 6 cycles of chemotherapy with SMILE regimen, and showed complete response with no recurrence in the follow-up.

We presented a rare case of ENKTL with tonsil involvement in a child. The patient showed complete response to the SMILE chemotherapy with no recurrence.

## Linked entities

- **Proteins:** CD2 (CD2 molecule), cd.3 (Cd.3 conserved hypothetical protein), CD4 (CD4 molecule), CD5 (CD5 molecule), CD8A (CD8 subunit alpha), TIA1 (TIA1 cytotoxic granule associated RNA binding protein)

## Full-text entities

- **Genes:** CD2 (CD2 molecule) [NCBI Gene 914] {aka LFA-2, SRBC, T11}, GZMB (granzyme B) [NCBI Gene 3002] {aka C11, CCPI, CGL-1, CGL1, CSP-B, CSPB}, TIA1 (TIA1 cytotoxic granule associated RNA binding protein) [NCBI Gene 7072] {aka ALS26, TIA-1, WDM}, CD5 (CD5 molecule) [NCBI Gene 921] {aka LEU1, T1}, CD4 (CD4 molecule) [NCBI Gene 920] {aka CD4mut, IMD79, Leu-3, OKT4D, T4}, CD8A (CD8 subunit alpha) [NCBI Gene 925] {aka CD8, CD8alpha, IMD116, Leu2, p32}
- **Diseases:** calcification (MESH:D002114), granulomatous inflammation (MESH:D007249), ENKTL (MESH:D000077428), PRESENTATION (MESH:D001946), hypertrophy (MESH:D006984), suppurative tonsilitis (MESH:D014069), fever (MESH:D005334), squamous epithelial hyperplasia (MESH:D017573), sore throat (MESH:D010612)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC11290306/full.md

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC11290306/full.md

## References

1 references — full list in the complete paper: https://tomesphere.com/paper/PMC11290306/full.md

---
Source: https://tomesphere.com/paper/PMC11290306